美国患有阿片类药物使用障碍的育儿妇女接受行为健康治疗的情况。

IF 1.8 4区 医学 Q2 NURSING
Stacey E. Iobst, Priscilla Novak, Mir M. Ali
{"title":"美国患有阿片类药物使用障碍的育儿妇女接受行为健康治疗的情况。","authors":"Stacey E. Iobst,&nbsp;Priscilla Novak,&nbsp;Mir M. Ali","doi":"10.1016/j.jogn.2024.01.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.</p></div><div><h3>Design</h3><p>Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.</p></div><div><h3>Setting</h3><p>United States.</p></div><div><h3>Participants</h3><p>Women aged 18 to 44 years with opioid use disorder and at least one child in the household.</p></div><div><h3>Methods</h3><p>We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.</p></div><div><h3>Results</h3><p>Of the 36% of respondents in our weighted sample (<em>N</em> ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.</p></div><div><h3>Conclusion</h3><p>Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.</p></div>","PeriodicalId":54903,"journal":{"name":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","volume":"53 4","pages":"Pages 355-367"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Behavioral Health Treatment Among Parenting Women With Opioid Use Disorder in the United States\",\"authors\":\"Stacey E. Iobst,&nbsp;Priscilla Novak,&nbsp;Mir M. Ali\",\"doi\":\"10.1016/j.jogn.2024.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.</p></div><div><h3>Design</h3><p>Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.</p></div><div><h3>Setting</h3><p>United States.</p></div><div><h3>Participants</h3><p>Women aged 18 to 44 years with opioid use disorder and at least one child in the household.</p></div><div><h3>Methods</h3><p>We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.</p></div><div><h3>Results</h3><p>Of the 36% of respondents in our weighted sample (<em>N</em> ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.</p></div><div><h3>Conclusion</h3><p>Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.</p></div>\",\"PeriodicalId\":54903,\"journal\":{\"name\":\"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing\",\"volume\":\"53 4\",\"pages\":\"Pages 355-367\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0884217524000042\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0884217524000042","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0

摘要

目的根据患有阿片类药物使用障碍的育儿女性在过去一年中是否出现重度抑郁发作,研究她们对心理健康治疗、药物使用障碍治疗的使用情况以及感知到的治疗障碍:对 2015-2019 年全国药物使用与健康调查的调查数据进行二次分析:环境:美国:年龄在 18-44 岁之间、患有阿片类药物使用障碍且家中至少有一个孩子的女性:我们计算了人口统计学特征、重度抑郁发作状态下的治疗情况以及重度抑郁发作状态下的治疗障碍的描述性统计。我们进行了多项式逻辑回归,以检验人口统计学特征、重度抑郁发作状态和治疗类型之间的关联:在我们的加权样本(样本数≈ 254,300 人)中,有 36% 的受访者经历过重度抑郁发作,其中 35% 接受了药物使用障碍和心理健康治疗,27% 没有接受任何形式的治疗。我们发现,有色人种身份与接受任何类型治疗的相对风险较低有显著关联。经常报告的治疗障碍包括负担能力、获取途径和污名化:结论:患有阿片类药物使用障碍并同时伴有重度抑郁发作的受访者没有获得必要的治疗。需要解决治疗障碍问题,包括负担能力、获得治疗的机会和耻辱感,尤其是在有色人种妇女中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Use of Behavioral Health Treatment Among Parenting Women With Opioid Use Disorder in the United States

Objective

To examine use of mental health treatment, substance use disorder treatment, and perceived barriers to treatment by whether a major depressive episode occurred during the past year among parenting women with opioid use disorder.

Design

Secondary analysis of survey data from the National Survey on Drug Use and Health, 2015–2019.

Setting

United States.

Participants

Women aged 18 to 44 years with opioid use disorder and at least one child in the household.

Methods

We computed descriptive statistics for demographic characteristics, treatment by major depressive episode status, and barriers to treatment by major depressive episode status. We conducted multinomial logistic regression to examine associations among demographic characteristics, major depressive episode status, and type of treatment.

Results

Of the 36% of respondents in our weighted sample (N ≈ 254,300) who experienced major depressive episode, 35% received substance use disorder and mental health treatment, and 27% did not receive any form of treatment. We found that identification as a person of color was significantly associated with a lower relative risk of receiving any type of treatment. Frequently reported barriers to treatment included affordability, access, and stigma.

Conclusion

Respondents with opioid use disorder and co-occurring major depressive episode did not obtain necessary treatment. Barriers to treatment, including affordability, access to treatment, and stigma, need to be addressed, particularly among women of color.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.20
自引率
5.60%
发文量
0
审稿时长
43 days
期刊介绍: JOGNN is a premier resource for health care professionals committed to clinical scholarship that advances the health care of women and newborns. With a focus on nursing practice, JOGNN addresses the latest research, practice issues, policies, opinions, and trends in the care of women, childbearing families, and newborns. This peer-reviewed scientific and technical journal is highly respected for groundbreaking articles on important - and sometimes controversial - issues. Articles published in JOGNN emphasize research evidence and clinical practice, building both science and clinical applications. JOGNN seeks clinical, policy and research manuscripts on the evidence supporting current best practice as well as developing or emerging practice trends. A balance of quantitative and qualitative research with an emphasis on biobehavioral outcome studies and intervention trials is desired. Manuscripts are welcomed on all subjects focused on the care of women, childbearing families, and newborns.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信